Concord Biotech Limited has informed the Exchange regarding Cessation of Mr Prakash Sajnani as Company Secretary & Compliance Officer of the company w.e.f. May 29, 2025.
CONCORDBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.3 pts less than Nifty Smallcap 250 and 0.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Mr. Prakash Sajnani has resigned as Company Secretary & Compliance Officer of Concord Biotech Limited, effective from the close of business hours on May 29, 2025. He is stepping down due to increased responsibilities in the Accounts and Finance department following the company's public listing, where stricter regulatory and reporting requirements now apply. He will continue in his existing role as Assistant Vice President – Accounts & Finance, meaning the company retains his financial expertise. As a result, he will also cease to be a Key Managerial Personnel (KMP) under Section 203 of the Companies Act, 2013. The management has accepted the resignation and no other material reasons were cited.
This is a routine KMP-level change and should not materially affect operations since Mr. Sajnani stays with the company in a finance role; investors should watch for the appointment of a new Company Secretary & Compliance Officer in the coming weeks.